Edgar Filing: NOVAMED INC

Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): August 4, 2004

NovaMed, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware

0-26625

36-4116193

(State or Other Jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)


980 North Michigan Avenue, Suite 1620, Chicago, Illinois		60611
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code (312) 664-4100

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

(c)

Exhibits


Exhibit Number		Title
99.1		Press release of NovaMed, Inc. dated August 4, 2004

Item 12. Results of Operations & Financial Condition.

The following information is furnished pursuant to Item 12. “Results of Operations & Financial Condition” in accordance with SEC Release No. 33-8216.

On August 4, 2004, NovaMed, Inc. issued a press release announcing its results of operations for the period ended June 30, 2004. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	NovaMed, Inc.

Dated: August 4, 2004	By:	/s/ Stephen J. Winjum
		Stephen J. Winjum
		President and Chief Executive Officer

EXHIBIT INDEX


Exhibit No.		Exhibit
99.1		Press Release of NovaMed, Inc. dated August 4, 2004.